Related Experiment Video
Updated: Jun 27, 2026

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
Published on: July 17, 2012
Role of p38 mitogen-activated protein kinases in cardioprotection of morphine preconditioning
Ye Zhang1, Er-wei Gu, Jian Zhang
1Department of Anesthesiology, First Affiliated Hospital of Anhui Medical University, Hefei 230022, China. zhangye@mail.hf.ah.cn
Background:
p38 mitogen-activated protein kinases (MAPK) in ischemic preconditioning (IPC) may be essential to cardioprotection. We assessed whether protective effect of morphine-induced preconditioning (MPC) on myocardial ischemia and reperfusion injury in rat hearts involved p38 MAPK activation.
Methods:
Male Spargue-Dawley rats (weighing 300-350 g) were randomly assigned to 1 of the following 8 groups: control (CON, saline vehicle, n=9), SB 203580 (SB, a p38 MAPK inhibitor, n=6), MPC (n=6), IPC (n=9), SB+MPC, SB+IPC, MPC+SB, and IPC+SB (n=6). Infarct sizes (IS), a percentage of the area at risk (AAR), were determined by triphenyltetrazolium (TTC) staining. Tissue samples were processed from the entire AAR of left ventricle for the determination of p38 MAPK protein expression (5 hearts/group). The bands representing the proteins were visualized using an enhanced chemiluminescence detection system.
Results:
The IS/AAR was significantly reduced by IPC (12.9+/-1.6)% or MPC (25.3+/-2.9)% compared to the control (52.7+/-5.5)%. SB 203580 administered prior to preconditioning abolished the effect of IPC (SB+IPC: (43.8+/-2.6)%, P>0.05 vs CON, P<0.01 vs IPC), but not MPC (SB+MPC: (30.7+/-0.9)%, P<0.01 vs CON, P>0.05 vs MPC). Treatment with SB 203580 prior to sustained ischemia diminished the protective effect of both MPC (MPC+SB: (42.4+/-2.9)%, P>0.05 vs CON) and IPC (IPC+SB: (52.0+/-2.5)%, P>0.05 vs CON) on IS/AAR. In the IPC group, phospho-p38 MAPK protein increased significantly within 5 minutes into ischemia and remained elevated at 30 minutes into reperfusion, while phospho-p38 MAPK protein in the MPC group only increased significantly at 30 minutes into reperfusion.
Conclusion:
The activation of p38 MAPK just acts as a mediator of MPC, whereas it acts as both a trigger and a mediator in IPC.
Insights
Morphine-induced preconditioning (MPC) and ischemic preconditioning (IPC) protect rat hearts from injury. p38 mitogen-activated protein kinases (MAPK) mediate MPC, but trigger and mediate IPC.
Area of Science:
- Cardiovascular Science
- Molecular Cardiology
- Pharmacology
Background:
- p38 mitogen-activated protein kinases (MAPK) are crucial for cardioprotection during ischemic preconditioning (IPC).
- The role of p38 MAPK in morphine-induced preconditioning (MPC) remains unclear.
Purpose of the Study:
- To investigate whether p38 MAPK activation mediates the protective effects of MPC against myocardial ischemia-reperfusion injury in a rat model.
- To compare the role of p38 MAPK in MPC versus IPC.
Main Methods:
- Male Spargue-Dawley rats were subjected to control, p38 MAPK inhibition (SB 203580), MPC, IPC, or combinations thereof.
- Infarct size (IS) as a percentage of area at risk (AAR) was determined using triphenyltetrazolium staining.
- p38 MAPK protein expression was assessed via Western blotting.
Main Results:
- Both IPC and MPC significantly reduced infarct size compared to control.
- Inhibition of p38 MAPK abolished the protective effect of IPC but not MPC when administered before preconditioning.
- Inhibition of p38 MAPK prior to sustained ischemia diminished the protective effects of both MPC and IPC.
- Phospho-p38 MAPK levels increased rapidly during ischemia and reperfusion in IPC, but only during reperfusion in MPC.
Conclusions:
- p38 MAPK acts as a mediator in MPC.
- p38 MAPK functions as both a trigger and a mediator in IPC.
- These findings differentiate the mechanistic roles of p38 MAPK in two distinct preconditioning paradigms.
Related Concept Videos
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids

